嘉澤新能(601619.SH):二級子公司資源縣楓樹灣風電場項目獲核准
格隆匯6月6日丨嘉澤新能(601619.SH)公佈,公司二級子公司桂林市資源縣澤華能源發展有限公司於日前收到了《廣西壯族自治區發展和改革委員會關於桂林市資源縣楓樹灣風電場核准的批覆》文件,同意建設資源縣楓樹灣風電場項目。項目單位為桂林市資源縣澤華能源發展有限公司;項目建設地點位於桂林市資源縣車田苗族鄉;項目裝機容量為100兆瓦,配套裝機容量20%、2小時的儲能(即40兆瓦時儲能);項目總投資7.9879億元。其中項目資本金1.5916億元,佔項目總投資的比例為20%,由項目單位以自有資金出資,其餘通過向銀行貸款等方式解決。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.